Why Should You Attend:
This presentation begins with an overview of the biological self versus non-self mechanism resulting in the anti-drug response of biopharmaceuticals. The next section describes how to differentiate the risk associated with internal attributes of the drug from the risk derived from external factors. That guideline in conjunction with the latest industry recommendations and regulatory guidelines provides a logical approach to the risk strategy.
Organizer:
ComplianceOnline
More information about Managing Immunogenicity Risk in Biopharmaceuticals - Webinar By ComplianceOnline »